Clinically relevant mutations in CaBPs are associated with a range of pathogenic phenotypes, including autosomal recessive hearing loss caused by mutations in CaBP2, as well as various visual disorders, dystrophies, and frontal lobe epilepsy linked to CaBP4 mutations. This evidence concerns the gene CABP2 and autosomal dominant nonsyndromic hearing loss.